Cannabis finance news

Althea claims profitability ‘is close’ despite pharmaceutical nosedive

by Steve Jones March 3, 2025March 4, 2025

Cost savings enabled Althea to narrow losses in the first half of FY25 as the company […]

Big pharma makes CBD over-the-counter move as Sandoz strikes 10-year deal with Avecho

by Steve Jones March 3, 2025April 29, 2026

Pastilles drive Bioxyne to first-half profit after revenue climbs 171%

by Steve Jones March 3, 2025March 3, 2025

ECS Botanics posts A$2m loss but flags record orders for second half of FY25

by Steve Jones March 2, 2025March 3, 2025

Cann Group revenue falls but losses narrow as focus turns to ‘critical’ restructuring of finances

by Steve Jones March 1, 2025March 3, 2025

News in brief: LCWA; Epsilon; Vitura Health; NZ hemp rules

by Martin Lane February 26, 2025February 26, 2025

Vitura growth plan ‘might take a bit longer’, admits CEO as medical cannabis prices continue to fall

by Steve Jones February 26, 2025February 26, 2025

Greenfern goes into receivership as senior leaders resign

by Steve Jones February 25, 2025February 25, 2025

How to win a Cannabiz Award webinar

by cannabiz team February 24, 2025February 24, 2025

Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO

by Steve Jones February 20, 2025February 20, 2025